About Carbonic anhydrase 5B, mitochondrial
Carbonic anhydrase 5B, mitochondrial (CA5B) is a protein
from Homo sapiens identified by UniProt accession
Q9Y2D0, 317 residues long.
MolForge cross-references it against 0 known binders and
36 disease associations.
Target properties
| Protein name | Carbonic anhydrase 5B, mitochondrial |
| UniProt accession | Q9Y2D0 |
| Gene | CA5B |
| Organism | Homo sapiens |
| Length | 317 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (16)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (36)
Diseases linked to this target (Open Targets).
- epilepsy · score 0.44
- neurodegenerative disease · score 0.21
- obstructive sleep apnea · score 0.07
- Duchenne muscular dystrophy · score 0.01
- osteosarcoma · score 0.01
- atrial fibrillation · score 0.01
- clostridium difficile infection · score 0.01
- cerebral amyloid angiopathy · score 0.01
- hypertrophy · score 0.01
- allergic rhinitis · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9Y2D0-F1 | alphafold | PREDICTED | 83.18 | — |
Amino-acid sequence (317 residues)
MVVMNSLRVI LQASPGKLLW RKFQIPRFMP ARPCSLYTCT YKTRNRALHP LWESVDLVPG GDRQSPINIR WRDSVYDPGL KPLTISYDPA TCLHVWNNGY SFLVEFEDST DKSVIKGGPL EHNYRLKQFH FHWGAIDAWG SEHTVDSKCF PAELHLVHWN AVRFENFEDA ALEENGLAVI GVFLKLGKHH KELQKLVDTL PSIKHKDALV EFGSFDPSCL MPTCPDYWTY SGSLTTPPLS ESVTWIIKKQ PVEVDHDQLE QFRTLLFTSE GEKEKRMVDN FRPLQPLMNR TVRSSFRHDY VLNVQAKPKP ATSQATP
Explore Carbonic anhydrase 5B, mitochondrial with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets